Antiepileptic drugs in the treatment of bipolar disorder

Author/s
Mark Lyons, David Taylor
Citation
Issue 3 Summer 2013
CEPiP.2013;1:151-158
Abstract

Antiepileptic drugs (AEDs) were first shown to be effective in mania nearly 40 years ago (1973 carbamazepine; 1975 valproate). The discovery that carbamazepine and valproate are effective for mania encouraged interest in other antiepileptic agents as potential treatments. Although the exact mechanism of action of the AEDs in Bipolar Affective Disorder (BPD) is not fully understood, these drugs have provided a successful means of treating and managing a very complex illness. This review aims to summarise the effect of five of the most commonly used AEDs for acute mania, bipolar depression, prophylaxis of BPD, and rapid cycling BPD.

Cite as: Cutting Edge Psychiatry in Practice 2013, 3(1):151-158; https://doi.org/10.65031/kleh1157

References

  1. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 1973; 27 (4):283-297. https://doi.org/10.1111/j.1440-1819.1973.tb02661.x
  2. Lambert PA, Carraz G, Borselli S, Bouchardy M. [Dipropylacetamide in the treatment of manic-depressive psychosis]. Encephale 1975; 1 (1):25-31.
  3. Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania. J Clin Psychiatry 2010; 71 (4):426-432. https://doi.org/10.4088/jcp.08m04960yel
  4. Bowden C, Gogus A, Grunze H, Haggstrom L, Rybakowski J, Vieta E. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Int Clin Psychopharmacol 2008; 23 (5):254-262. https://doi.org/10.1097/yic.0b013e3282fd827c
  5. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375 (9712):385-395. https://doi.org/10.1016/s0140-6736(09)61828-6
  6. Novick D, Gonzalez-Pinto A, Haro JM, Bertsch J, Reed C, Perrin E et al. Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study. Pharmacopsychiatry 2009; 42 (4):145-152. https://doi.org/10.1055/s-0028-1128115
  7. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011; 378 (9799):1306-1315. https://doi.org/10.1016/s0140-6736(11)60873-8
  8. Smith LA, Cornelius VR, Azorin JM, Perugi G, Vieta E, Young AH et al. Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord 2010; 122 (1-2):1-9. https://doi.org/10.1016/j.jad.2009.10.033
  9. Bond DJ, Lam RW, Yatham LN. Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. J Affect Disord 2010; 124 (3):228-234. https://doi.org/10.1016/j.jad.2009.11.008
  10. Taylor D, Paton C, Kapur S. Maudsley Prescribing Guidelines in Psychiatry - 11th Edition. Oxford, UK, Wiley-Blackwell, 2012.
  11. Kessing LV, Hellmund G, GEDDES JR, GOODWIN GM, Andersen PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. The British Journal of Psychiatry 2011; 199 (1):57-63. https://doi.org/10.1192/bjp.bp.110.084822
  12. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160 (7):1263-1271. https://doi.org/10.1176/appi.ajp.160.7.1263
  13. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition-- recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23 (4):346-388. https://doi.org/10.1177/0269881109102919
  14. National Institute for Clinical Excellence. Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical Guidance 38. http://www. nice.org.uk . 2006. https://doi.org/10.1097/01.yic.0000405630.12858.76
  15. Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry 2009; 70 (1):113-121. https://doi.org/10.4088/jcp.07m04022
  16. Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S et al. A 20-month, double- blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162 (11):2152-2161. https://doi.org/10.1176/appi.ajp.162.11.2152
  17. Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H et al. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol 2008; 28 (5):555-560. https://doi.org/10.1097/jcp.0b013e318185e75f
  18. Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J Psychiatr Res 2008; 42 (13):1068-1075. https://doi.org/10.1016/j.jpsychires.2007.12.004
  19. GlaxoSmithKline UK. Summary of Product Characteristics. Lamictal. 2013. http://www.medicines.org.uk/.         
  20. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009; 194 (1):4-9. https://doi.org/10.1192/bjp.bp.107.048504
  21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
  22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389. https://doi.org/10.1192/bjp.134.4.382
  23. Brown EB, McElroy SL, Keck PE, Jr., Deldar A, Adams DH, Tohen M et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006; 67 (7):1025-1033. https://doi.org/10.4088/jcp.v67n0703
  24. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60 (4):392-400. https://doi.org/10.1001/archpsyc.60.4.392
  25. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64 (9):1013-1024. https://doi.org/10.4088/jcp.v64n0906
  26. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL et al. A double-blind, placebo- controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61 (11):841-850. https://doi.org/10.4088/jcp.v61n1106
  27. Bowden CL, Singh V. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder. Expert Opin Pharmacother 2012; 13 (17):2565-2571. https://doi.org/10.1517/14656566.2012.741590
  28. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435. https://doi.org/10.1192/bjp.133.5.429
  29. Weisler RH, Kalali AH, Ketter TA. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65 (4):478-484. https://doi.org/10.4088/jcp.v65n0405
  30. Weisler RH, Keck PE, Jr., Swann AC, Cutler AJ, Ketter TA, Kalali AH. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double- blind, placebo-controlled trial. J Clin Psychiatry 2005; 66 (3):323-330. https://doi.org/10.4088/jcp.v66n0308
  31. Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 2008; 192 (2):135-143. https://doi.org/10.1192/bjp.bp.107.041301
  32. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993; 27 (3):138-145. https://doi.org/10.1159/000118969
  33. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987; 48 (3):89-93.
  34. Dilsaver SC, Swann SC, Chen YW, Shoaib A, Joe B, Krajewski KJ et al. Treatment of bipolar depression with carbamazepine: results of an open study. Biol Psychiatry 1996; 40 (9):935-937. https://doi.org/10.1016/s0006-3223(96)00339-3
  35. Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS. Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. Hum Psychopharmacol 2009; 24 (1):19-28. https://doi.org/10.1002/hup.990
  36. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003; 64 (2):144-151. https://doi.org/10.4088/jcp.v64n0206
  37. Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. J Affect Disord 1997; 43 (2):151-161. https://doi.org/10.1016/s0165-0327(96)01427-9
  38. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000; 42 Suppl 1:2-10. https://doi.org/10.1159/000054844
  39. Joyce PR. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 1988; 3 (2):123-129. https://doi.org/10.1097/00004850-198804000-00003
  40. Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991; 83 (6):456-459. https://doi.org/10.1111/j.1600-0447.1991.tb05575.x
  41. Williams JW, Jr., Ranney L, Morgan LC, Whitener L. How reviews covered the unfolding scientific story of gabapentin for bipolar disorder. Gen Hosp Psychiatry 2009; 31 (3):279-287. https://doi.org/10.1016/j.genhosppsych.2009.02.006
  42. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2 (3 Pt 2):249-255. https://doi.org/10.1034/j.1399-5618.2000.20305.x
  43. Guy W. In: Guy W Ed, ECDEU Assessment Manual for Psychopharmacology Rev Ed. Rockville , MD, National Institute of Mental Health, 1976; 157-169.
  44. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20 (6):607-614. https://doi.org/10.1097/00004714-200012000-00004
  45. Fullerton CA, Busch AB, Frank RG. The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion. Med Care 2010; 48 (4):372-379. https://doi.org/10.1097/mlr.0b013e3181ca404e
  46. Obrocea GV, Dunn RM, Frye MA, Ketter TA, Luckenbaugh DA, Leverich GS et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002; 51 (3):253-260. https://doi.org/10.1016/s0006-3223(01)01206-9
  47. Vieta E, Manuel GJ, Martinez-Aran A, Comes M, Verger K, Masramon X et al. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. J Clin Psychiatry 2006; 67 (3):473-477. https://doi.org/10.4088/jcp.v67n0320
  48. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002; 4 (3):207-213. https://doi.org/10.1034/j.1399-5618.2002.01189.x
  49. Vieta E, Goikolea JM, Olivares JM, Gonzalez-Pinto A, Rodriguez A, Colom F et al. 1-year follow-up of patients treated with risperidone and topiramate for a manic episode. J Clin Psychiatry 2003; 64 (7):834-839. https://doi.org/10.4088/jcp.v64n0715
  50. Sanofi. Summary of Product Characteristics. Depakote 250mg Tablets. 2012. http://www.medicines.org.uk/.     
  51. CADE JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2 (10):349-352.